drugset / Trial / NCT05263895
Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to estimate the relative bioavailability of PF-07321332 in different formulations in healthy adult participants.
Timeline
- Start
- 2022-03-03
- Primary completion
- 2022-05-16
- Completion
- 2022-05-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nirmatrelvir | Small molecule | — | Oral |
| Subject | Ritonavir | Other / unclassified | — | Oral |
Indications
No indication recorded.